Abbott Laboratories (ABT.N) said it would sell its eye care business to Johnson & Johnson (JNJ.N) for about $4.33 billion in cash to focus on cardiovascular devices and diagnostics business.
|
|
Scooped by
Enzo Calamo
onto Business Report - Making A Difference September 17, 2016 10:56 AM
|
No comment yet.
Sign up to comment
Your new post is loading...

